AU2881399A - N1-modified glycopeptides - Google Patents

N1-modified glycopeptides

Info

Publication number
AU2881399A
AU2881399A AU28813/99A AU2881399A AU2881399A AU 2881399 A AU2881399 A AU 2881399A AU 28813/99 A AU28813/99 A AU 28813/99A AU 2881399 A AU2881399 A AU 2881399A AU 2881399 A AU2881399 A AU 2881399A
Authority
AU
Australia
Prior art keywords
modified glycopeptides
glycopeptides
modified
compounds
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28813/99A
Other languages
English (en)
Inventor
Richard Craig Thompson
Stephen Charles Wilkie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2881399A publication Critical patent/AU2881399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU28813/99A 1998-05-01 1999-02-26 N1-modified glycopeptides Abandoned AU2881399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8387998P 1998-05-01 1998-05-01
US60083879 1998-05-01
PCT/US1999/004306 WO1999056760A1 (en) 1998-05-01 1999-02-26 N1-modified glycopeptides

Publications (1)

Publication Number Publication Date
AU2881399A true AU2881399A (en) 1999-11-23

Family

ID=22181253

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28813/99A Abandoned AU2881399A (en) 1998-05-01 1999-02-26 N1-modified glycopeptides

Country Status (10)

Country Link
US (3) US6670446B1 (enExample)
EP (1) EP1073447B1 (enExample)
JP (1) JP4307723B2 (enExample)
AT (1) ATE361931T1 (enExample)
AU (1) AU2881399A (enExample)
CA (1) CA2330619A1 (enExample)
DE (1) DE69936052T2 (enExample)
DK (1) DK1073447T3 (enExample)
ES (1) ES2283107T3 (enExample)
WO (1) WO1999056760A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2330619A1 (en) * 1998-05-01 1999-11-11 Eli Lilly And Company N1-modified glycopeptides
US6392012B1 (en) 1998-12-23 2002-05-21 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
AU4054900A (en) * 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
US6699836B2 (en) 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
AU2001238180B8 (en) 2000-02-11 2006-07-27 Eli Lilly And Company Selective N-acylation of A82846 glycopeptide analogs
AR053347A1 (es) 2005-04-06 2007-05-02 Astrazeneca Ab Derivados de [1,3]tiazolo[4,5-d]pirimidin-2(3h)-ona 5,7-sustituidos
UA90707C2 (en) 2005-04-06 2010-05-25 Астразенека Аб Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
CA2623198C (en) 2005-09-22 2014-08-05 Medivas, Llc Bis-(a-amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
WO2007038246A2 (en) 2005-09-22 2007-04-05 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
US8841440B2 (en) 2008-04-01 2014-09-23 Cornell University Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4639433A (en) 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
US4643987A (en) 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
EG18377A (en) * 1986-09-19 1993-04-30 Lilly Co Eli Process for preparing glycopeptide antibiotics
US5534420A (en) 1988-07-28 1996-07-09 Eli Lilly And Company Biotransformation of glycopeptide antibiotics
ZA909847B (en) 1989-12-13 1992-08-26 Lilly Co Eli Glycopeptide derivatives
NZ270387A (en) 1994-01-28 1996-11-26 Lilly Co Eli Glycopeptide antibiotic, its production and compositions thereof
US5952310A (en) * 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
CA2330619A1 (en) * 1998-05-01 1999-11-11 Eli Lilly And Company N1-modified glycopeptides

Also Published As

Publication number Publication date
DE69936052T2 (de) 2008-01-17
EP1073447B1 (en) 2007-05-09
CA2330619A1 (en) 1999-11-11
ES2283107T3 (es) 2007-10-16
ATE361931T1 (de) 2007-06-15
DE69936052D1 (de) 2007-06-21
DK1073447T3 (da) 2007-09-03
US20060128609A1 (en) 2006-06-15
US20050037950A1 (en) 2005-02-17
US6939947B2 (en) 2005-09-06
EP1073447A1 (en) 2001-02-07
JP4307723B2 (ja) 2009-08-05
US6670446B1 (en) 2003-12-30
EP1073447A4 (en) 2001-10-04
JP2002513764A (ja) 2002-05-14
WO1999056760A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
EP1193270A3 (en) Pyrrolobenzodiazepines
PL348451A1 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
AP9901534A0 (en) Pharmaceutical formulations.
AU3951699A (en) The use of an anti-microbial compound for disinfection
AU4461193A (en) 9-{substituted glycyl)amido}-6-demethyl-6-deoxyte tracyclines
CY2543B1 (en) 9-Ä(Substituted glycyl)amidoÜ-6-(substituted)-5-hydroxy-6-deoxytetracyclines
AU4461293A (en) 7-(substituted)-9-{(substituted glycyl)amido}-6-demethyl-6- deoxytetracyclines
AU8258698A (en) Isoquinoline-indole compounds as antimicrobial agents
AU7026794A (en) Phosphonooxymethyl ethers of taxane derivatives
AU2906495A (en) Antimicrobial compositions useful for medical applications
BR9808491A (pt) Compostos calcilìticos
AU3973697A (en) Isoxazoline derivatives useful as antimicrobials
MY127081A (en) Glycopeptide phosphonate derivatives
AU4930299A (en) Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives
BR0112452A (pt) Derivados de pleuromutilinas tendo atividade antibacteriana
CA2152771A1 (en) 7-o-ethers of taxane derivatives
AU2491395A (en) New benzothiadiazine compound, process for its preparation and the pharmaceutical compositions which contain it
EP1073447A4 (en) N1-MODIFIED GLYCOPEPTIDES
CA2352392A1 (en) Eletriptan hydrobromide monohydrate
AP9400632A0 (en) Ether derivatives.
AU3774097A (en) Intermediates for the preparation of 2-imidazoline-5-ones
AU1516300A (en) Benzoquinoline derivatives useful as antibacterial agents
AU5994696A (en) Modified alpha-d-glcp-(1-2)-alpha-d-glcp-(1-3)-alpha-d-glcp- analogues
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
AU1783700A (en) 1,8-benzonaphthyridine derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase